Skip to content
  • About GRP
    • Why Choose Us
    • Leadership
    • Brochure
    • Careers
  • Countries
    • Canada’s Health Canada
    • United States’ FDA
    • Brazil
    • Mexico’s COFEPRIS
    • Europe’s EMA
    • Australia
    • China
    • Japan’s PMDA
    • Korea’s Ministry of Food and Drug Safety (MFDS)
    • Taiwan’s Food and Drug Administration (TFDA)
    • Singapore’s HSA
    • India’s CDSCO

    North America

    Canada

    United States of America

    Latin AMerica

    Brazil

    Mexico

    Europe

    European Union

    Australia

    Australia

    Asia

    China

    Japan

    South Korea

    Taiwan

    Singapore

    India

  • Services

    Medical Devices

    • Authorized Local Agent
    • Regulatory Intelligence
    • Regulatory Strategy
    • Regulatory Affairs
    • Product Registration
    • Medical Writing
    • Health Authority Consultation
    • Clinical

    Pharmaceuticals

    • Authorized Local Agent
    • Regulatory Intelligence
    • Regulatory Strategy
    • Regulatory Affairs
    • Product Registration
    • Regulatory Operations
    • Health Authority Consultation

    Nutraceuticals / Food Supplements

    • Authorized Local Agent
    • Regulatory Intelligence
    • Regulatory Affairs
    • Regulatory Strategy
    • Verification of Nutrient Claims
    • Verification of Health Claims

    Cosmetics & Personal Care Products

    • Authorized Local Agent
    • Regulatory Intelligence
    • Regulatory Affairs
    • Regulatory Strategy
    • Cosmetic Packaging and Labeling Review
    • Product Classification and Formulation Review

    Pharmacovigilance

    • Overview
    • GRP Pharmacoviglance Services

    Quality

    • Preparation for FDA Inspections
    • GMP Mockup Quality Audits
    • ISO 13485 Quality Audits
    • GCP Audits
    • cGTP Audits
    • GAP Analysis Audits
    • Foreign Manufacture Accreditation (FMA)
    • QA SOPs Development
  • Resource Center
    • Blog
    • Market Access Special Programs
    • Press Releases
    • White Papers
    • Case Studies
    • Videos
    • Presentations
    • Brochure
  • RI Platform
    • Japan Regulatory Intelligence (RI)
    • China (NMPA) Regulatory Intelligence
    • Brazil
    • Mexico Regulatory Intelligence (RI)
    • USA Regulatory Intelligence (RI)

    Japan

    • Health Authority
    • Medical Device
    • Pharmaceuticals
    • Clinical Trials
    • Cosmetics
    • Food Supplements

    China

    • Health Authority
    • Medical Device
    • Pharmaceuticals
    • Clinical Trials
    • Cosmetics
    • Food Supplements

    Brazil

    • Health Authority
    • Medical Device
    • Pharmaceuticals
    • Clinical Trials
    • Cosmetics
    • Food Supplements

    Mexico

    • Health Authority
    • Medical Device
    • Pharmaceuticals
    • Clinical Trials
    • Cosmetics
    • Food Supplements

    USA

    • Medical Device
    • Pharmaceuticals
    • Clinical Trials
    • Cosmetics
    • Food Supplements
  • Contact Us
  • About GRP
    • Why Choose Us
    • Leadership
    • Brochure
    • Careers
  • Countries
    • Canada’s Health Canada
    • United States’ FDA
    • Brazil
    • Mexico’s COFEPRIS
    • Europe’s EMA
    • Australia
    • China
    • Japan’s PMDA
    • Korea’s Ministry of Food and Drug Safety (MFDS)
    • Taiwan’s Food and Drug Administration (TFDA)
    • Singapore’s HSA
    • India’s CDSCO
  • Services
  • Resource Center
    • Blog
    • Market Access Special Programs
    • Press Releases
    • White Papers
    • Case Studies
    • Videos
    • Presentations
    • Brochure
  • RI Platform
    • Japan Regulatory Intelligence (RI)
    • China (NMPA) Regulatory Intelligence
    • Brazil
    • Mexico Regulatory Intelligence (RI)
    • USA Regulatory Intelligence (RI)
  • Contact Us
  • About GRP
    • Why Choose Us
    • Leadership
    • Brochure
    • Careers
  • Countries
    • Canada’s Health Canada
    • United States’ FDA
    • Brazil
    • Mexico’s COFEPRIS
    • Europe’s EMA
    • Australia
    • China
    • Japan’s PMDA
    • Korea’s Ministry of Food and Drug Safety (MFDS)
    • Taiwan’s Food and Drug Administration (TFDA)
    • Singapore’s HSA
    • India’s CDSCO
  • Services
  • Resource Center
    • Blog
    • Market Access Special Programs
    • Press Releases
    • White Papers
    • Case Studies
    • Videos
    • Presentations
    • Brochure
  • RI Platform
    • Japan Regulatory Intelligence (RI)
    • China (NMPA) Regulatory Intelligence
    • Brazil
    • Mexico Regulatory Intelligence (RI)
    • USA Regulatory Intelligence (RI)
  • Contact Us
Home / Products / Page 10

Showing 145–155 of 155 results

  • TECHNICAL REGULATION: ESSENTIAL REQUIREMENTS FOR SAFETY AND EFFICACY OF MEDICAL DEVICES

    TECHNICAL REGULATION: ESSENTIAL REQUIREMENTS FOR SAFETY AND EFFICACY OF MEDICAL DEVICES

    $30.00
    Add to cart
  • TECHNICAL REGULATION: THE REGISTRATION OF MEDICAL PRODUCTS AT ANVISA: ALTERATION, REVALIDATION, OR CANCELLATION (ANNEXES)

    TECHNICAL REGULATION: THE REGISTRATION OF MEDICAL PRODUCTS AT ANVISA: ALTERATION, REVALIDATION, OR CANCELLATION (ANNEXES)

    $300.00
    Add to cart
  • TECHNICAL REQUIREMENTS FOR AUTHORIZATION OF PERSONEL CARE PRODUCTS, COSMETICS AND PERFUMES

    TECHNICAL REQUIREMENTS FOR AUTHORIZATION OF PERSONEL CARE PRODUCTS, COSMETICS AND PERFUMES

    $30.00
    Add to cart
  • TECHNICAL REQUIREMENTS FOR CHILDREN'S PERSONAL CARE PRODUCTS, COSMETICS AND PERFUMES

    TECHNICAL REQUIREMENTS FOR CHILDREN’S PERSONAL CARE PRODUCTS, COSMETICS AND PERFUMES

    $100.00
    Add to cart
  • TECHNICAL REQUIREMENTS FOR INSECT REPELLENT (COSMETIC PRODUCTS) REGISTRATION

    TECHNICAL REQUIREMENTS FOR INSECT REPELLENT (COSMETIC PRODUCTS) REGISTRATION

    $30.00
    Add to cart
  • TECHNOVIGILANCE RULES APPLICABLE TO REGISTRATION HOLDERS IN BRAZIL

    TECHNOVIGILANCE RULES APPLICABLE TO REGISTRATION HOLDERS IN BRAZIL

    $75.00
    Add to cart
  • THE REGISTRATION OF VITAMINS, MINERALS, AMINO ACIDS AND PROTEINS CLASSIFIED AS SPECIFIC MEDICINES FOR ORAL USE

    THE REGISTRATION OF VITAMINS, MINERALS, AMINO ACIDS AND PROTEINS CLASSIFIED AS SPECIFIC MEDICINES FOR ORAL USE

    $50.00
    Add to cart
  • Transfer of Marketing Authorization in Japan

    Transfer of Marketing Authorization in Japan

    Read more
  • US FDA Guidance: Best Practices in Developing Proprietary Names for Human Prescription Drug Products

    US FDA Guidance: Best Practices in Developing Proprietary Names for Human Prescription Drug Products

    $5.00
    Add to cart
  • VALIDITY PERIOD OF REGULARIZATION OF PERSONAL HYGIENE PRODUCTS, COSMETICS, AND PERFUMES

    VALIDITY PERIOD OF REGULARIZATION OF PERSONAL HYGIENE PRODUCTS, COSMETICS, AND PERFUMES

    $10.00
    Add to cart
  • YAKUSHOKUKIHATSU No. 0331006/2006: Good Clinical Practices for Medical Devices

    YAKUSHOKUKIHATSU No. 0331006/2006: Good Clinical Practices for Medical Devices

    $200.00
    Add to cart
  • ←
  • 1
  • 2
  • 3
  • …
  • 7
  • 8
  • 9
  • 10

ABOUT GRP GROUP

  • About US
  • Leadership
  • Why Choose Us

Useful Links

  • Contact Us
  • Brochures
  • Resource Center

GRP Headquarters (USA)

303 Wyman Street, Suite 300
Waltham, MA. 02451, USA
Tel : (+1 ) 781 - 672 -4200
Info@globalregulatorypartners.com

GRP Group Offices

  • GRP USA
  • GRP Japan
  • GRP China
  • GRP Korea
  • GRP Brazil
  • GRP Mexico

Follow Us on Social Media

Twitter Youtube Linkedin
  • Privacy Policy
  • Terms & Conditions
  • Cookies Policy
  • Other Policies

Copyright ©2023 Global Regulatory Partners

Contact Us!